Solara Active Pharma Sciences Ltd to Review Quarterly Financial Results in Upcoming Board Meeting
Solara Active Pharma Sciences Limited has scheduled a meeting of its Board of Directors on Thursday, July 23, 2026. The primary objective of this meeting is to consider and approve the unaudited financial results for both Standalone and Consolidated positions for the quarter ended June 30, 2026.The board will also deliberate on other corporate matters during the proceedings scheduled for July 23, 2026.
Trading Window Closure for Designated Persons
In accordance with the company's Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of Solara Active Pharma Sciences Limited remains closed for designated persons. This restriction commenced on July 1, 2026, and will continue until 48 hours after the official announcement of the financial results.
The details regarding the upcoming board meeting and financial review are summarized below:
| Event Detail | Information |
|---|---|
| Company Name | Solara Active Pharma Sciences Limited |
| Meeting Date | July 23, 2026 |
| Period Covered | Quarter ended June 30, 2026 |
| Financial Statements | Standalone and Consolidated |
| Trading Window Status | Closed for designated persons from July 1, 2026 |
SOLARA Stock Price Movement
Solara Active Pharma Sciences Limited shares today slipped by 0.42% to settle at ₹575.20 after the market closed. The stock saw a total turnover of 76,119 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.